Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Announces First Japanese Certified Service Provider

NEW YORK (GenomeWeb News) – Mitsubishi Chemical Safety Institute has become the first Illumina certified genetic analysis service provider in Japan, Illumina announced today.
The Mitsubishi Chemical Safety Institute provides various analyses and services for pharmaceutical and chemical companies as well as for public institutions. It also offers whole-genome and targeted genotyping services using Illumina’s Infinium and GoldenGate assays.
Because of its involvement in toxicogenomic and pharmacogenomic investigations, MCSI “has acquired an abundance of experience in the development of genomic analysis technologies,” said Masaru Sekijima, general manager of the Advanced Medical Science Research Center at MCSI.
Companies participating in Illumina’s certified service provider program are required to undergo a certification process based on data generation and data certification in addition to an on-site facility and process audit.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.